SCHEMBL4590669

SCHEMBL4590669

C[C@H](COC(N)=O)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
CYP2D6 P10635 1/20 0.68
PKM P14618 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
TAAR1 Q96RJ0 2/20 0.48
LMNA P02545 3/20 0.47
KDM4E B2RXH2 1/20 0.47
ALOX5 P09917 1/20 0.44
ALDH1A1 P00352 1/20 0.44
AOC3 Q16853 2/20 0.44
KMT2A Q03164 1/20 0.44
SLC6A3 Q01959 3/20 0.43
DRD3 P35462 2/20 0.43
ADORA3 P0DMS8 1/20 0.43
EDNRB P24530 1/20 0.43
MAPK1 P28482 1/20 0.43
MC4R P32245 1/20 0.43
CYP2C19 P33261 1/20 0.43
MC3R P41968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28958757 1.00 CYP1A2 (0.68) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL4589554 1.00 CYP1A2 (0.68) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL20563823 0.90 CYP1A2 (0.56) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL528539 0.90 CYP1A2 (0.56) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL528806 0.86 SMN1; SMN2 (0.51) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
Carbamic Acid SCHEMBL9001050 0.86 CYP1A2 (0.50) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL1838254 0.85 CYP1A2 (0.47) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL1838251 0.85 CYP1A2 (0.47) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL23360815 0.84 CYP1A2 (0.47) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1
SCHEMBL8095371 0.84 CYP1A2 (0.51) CYP1A2SMN1; SMN2CYP2D6PKMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937656-A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS BETA 2 ADRENOCEPTOR AGONISTS AstraZeneca AB (SE) 2008-07-02 EP disclosed
WO-2007027134-A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS ASTRAZENECA AB (SE) 2007-03-08 WO disclosed